Josep Tarragó‐Celada

<i>De novo</i> <scp>MYC</scp> addiction as an adaptive response of cancer cells to <scp>CDK</scp> 4/6 inhibition

Míriam Tarrado‐Castellarnau, Pedro de Atauri, Josep Tarragó‐Celada et al. · Molecular Systems Biology · 2017 · 57 citations · Full text

Methylseleninic acid promotes antitumour effects via nuclear FOXO3a translocation through Akt inhibition

Míriam Tarrado‐Castellarnau, R. Cortès, Míriam Zanuy et al. · Pharmacological Research · 2015 · 47 citations · Full text

Oncology, Oncogenic Agent, Medicine +10

Cysteine and Folate Metabolism Are Targetable Vulnerabilities of Metastatic Colorectal Cancer

Josep Tarragó‐Celada, Carles Foguet, Míriam Tarrado‐Castellarnau et al. · Cancers · 2021 · 25 citations · Full text

Metastatic Cell Lines, Pathology, Metabolic Remodeling +16

Tracing metabolic fluxes using mass spectrometry: Stable isotope-resolved metabolomics in health and disease

Cristina Balcells, Carles Foguet, Josep Tarragó‐Celada et al. · TrAC Trends in Analytical Chemistry · 2019 · 19 citations

Stable Isotope-resolved Metabolomics, Biochemistry, Mass Spectrometry +10

Autonomous metabolic reprogramming and oxidative stress characterize endothelial dysfunction in acute myocardial infarction

Erika Zodda, Olga Tura-Ceide, Nicholas L. Mills et al. · eLife · 2023 · 17 citations · Full text